The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Hypertriglyceridemia secondary to obesity and diabetes
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675
Abdominal obesity and metabolic syndrome
Després, J.-P., & Lemieux, I. (2006) · Nature · doi:10.1038/nature05488 · Cited by 4,354
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001282 · Cited by 2,837
Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Brown, B. G., Zhao, X.-Q., Chait, A., Fisher, L. D., Cheung, M. C., Morse, J. S., Dowdy, A. A., Marino, E. K., Bolson, E. L., Alaupovic, P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011090 · Cited by 1,979
Self-citation
Research works printed but not linked: 71
- Carroll, 2005, Trends in serum lipids and lipoproteins of adults, 1960–2002, JAMA, 294, 1773, 10.1001/jama.294.14.1773 · DOI · Paper page
- D'Agostino, 2004, Cardiovascular disease risk factors predict the development of type 2 diabetes: the insulin resistance atherosclerosis study, Diabetes Care, 27, 2234, 10.2337/diacare.27.9.2234 · DOI
- Resnick, 2006, Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999–2002: the National Health and Nutrition Examination Survey, Diabetes Care, 29, 531, 10.2337/diacare.29.03.06.dc05-1254 · DOI · Paper page
- Brunzell, 1976, Myocardial infarction in the familial forms of hypertriglyceridemia, Metabolism, 25, 313, 10.1016/0026-0495(76)90089-5 · DOI · Paper page
- Hopkins, 2003, Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case–control comparison from the National Heart, Lung, and Blood Institute Family Heart Study, Circulation, 108, 519, 10.1161/01.CIR.0000081777.17879.85 · DOI · Paper page
- Goldberg, 2011, Triglycerides and heart disease: still a hypothesis?, Arterioscler. Thromb. Vasc. Biol., 31, 1716, 10.1161/ATVBAHA.111.226100 · DOI · Paper page
- Ginsberg, 2000, Insulin resistance and cardiovascular disease, J. Clin. Invest., 106, 453, 10.1172/JCI10762 · DOI · Paper page
- Zierath, 1998, Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway, Diabetologia, 41, 1343, 10.1007/s001250051075 · DOI · Paper page
- Kissebah, 1982, Relation of body fat distribution to metabolic complications of obesity, J. Clin. Endocrinol. Metab., 54, 254, 10.1210/jcem-54-2-254 · DOI · Paper page
- Seidell, 1988, Abdominal fat depots measured with computed tomography: effects of degree of obesity, sex, and age, Eur. J. Clin. Nutr., 42, 805
- Lewis, 2002, Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes, Endocr. Rev., 23, 201, 10.1210/er.23.2.201 · DOI
- Lewis, 1997, Fatty acid regulation of very low density lipoprotein production, Curr. Opin. Lipidol., 8, 146, 10.1097/00041433-199706000-00004 · DOI · Paper page
- Chan, 2002, Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration, Metabolism, 51, 1041, 10.1053/meta.2002.33339 · DOI
- Mauriege, 1995, Regional variation in adipose tissue metabolism of severely obese premenopausal women, J. Lipid Res., 36, 672, 10.1016/S0022-2275(20)40053-7 · DOI
- Byrne, 1995, Decreased non-esterified fatty acid suppression and features of the insulin resistance syndrome occur in a sub-group of individuals with normal glucose tolerance, Diabetologia, 38, 1358, 10.1007/BF00401770 · DOI
- Sadur, 1984, Insulin responsiveness of adipose tissue lipoprotein lipase is delayed but preserved in obesity, J. Clin. Endocrinol. Metab., 59, 1176, 10.1210/jcem-59-6-1176 · DOI
- Ginsberg, 2009, The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism, J. Lipid Res., 50, S162, 10.1194/jlr.R800090-JLR200 · DOI · Paper page
- Verges, 2010, Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes, Atherosclerosis, 211, 353, 10.1016/j.atherosclerosis.2010.01.028 · DOI
- Kissebah, 1982, Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non-insulin-dependent diabetes mellitus, Diabetes, 31, 217, 10.2337/diabetes.31.3.217 · DOI
- Vedala, 2006, Delayed secretory pathway contributions to VLDL-triglycerides from plasma NEFA, diet, and de novo lipogenesis in humans, J. Lipid Res., 47, 2562, 10.1194/jlr.M600200-JLR200 · DOI
- Matsubara, 2002, Decreased plasma adiponectin concentrations in women with dyslipidemia, J. Clin. Endocrinol. Metab., 87, 2764, 10.1210/jc.87.6.2764 · DOI · Paper page
- Lara-Castro, 2006, Adiponectin multimeric complexes and the metabolic syndrome trait cluster, Diabetes, 55, 249, 10.2337/diabetes.55.01.06.db05-1105 · DOI · Paper page
- Neumeier, 2007, High molecular weight adiponectin reduces apolipoprotein B and E release in human hepatocytes, Biochem. Biophys. Res. Commun., 352, 543, 10.1016/j.bbrc.2006.11.058 · DOI
- Qiao, 2008, Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism, Diabetes, 57, 1824, 10.2337/db07-0435 · DOI · Paper page
- Ginsberg, 2006, Metabolic syndrome: focus on dyslipidemia, Obesity (Silver Spring), 14, 41S, 10.1038/oby.2006.281 · DOI · Paper page
- Adiels, 2005, Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia, Arterioscler. Thromb. Vasc. Biol., 25, 1697, 10.1161/01.ATV.0000172689.53992.25 · DOI · Paper page
- Schneeman, 1993, Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans, Proc. Natl. Acad. Sci. U. S. A., 90, 2069, 10.1073/pnas.90.5.2069 · DOI · Paper page
- Federico, 2006, Diabetes, 55, 1316, 10.2337/db04-1084 · DOI
- Annuzzi, 2008, Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance, Nutr. Metab. Cardiovasc. Dis., 18, 531, 10.1016/j.numecd.2007.12.003 · DOI · Paper page
- Beigneux, 2010, GPIHBP1 and the processing of triglyceride-rich lipoproteins, Clin. Lipidol., 5, 575, 10.2217/clp.10.43 · DOI
- 1992, Lipid and lipoprotein levels in patients with IDDM diabetes control and complication. Trial experience. The DCCT Research Group, Diabetes Care, 15, 886, 10.2337/diacare.15.7.886 · DOI
- Weidman, 1982, Effects of insulin on plasma lipoproteins in diabetic ketoacidosis: evidence for a change in high density lipoprotein composition during treatment, J. Lipid Res., 23, 171, 10.1016/S0022-2275(20)38186-4 · DOI
- Purnell, 1998, Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial, JAMA, 280, 140, 10.1001/jama.280.2.140 · DOI · Paper page
- Purnell, 2003, Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the Diabetes Control and Complications Trial, Diabetes, 52, 2623, 10.2337/diabetes.52.10.2623 · DOI
- Verges, 2009, Lipid disorders in type 1 diabetes, Diab. Metab., 35, 353, 10.1016/j.diabet.2009.04.004 · DOI
- Lewis, 1991, Postprandial triglyceride response in type 1 (insulin-dependent) diabetes mellitus is not altered by short-term deterioration in glycaemic control or level of postprandial insulin replacement, Diabetologia, 34, 253, 10.1007/BF00405084 · DOI
- Guy, 2009, Lipid and lipoprotein profiles in youth with and without type 1 diabetes: the SEARCH for Diabetes in Youth case–control study, Diabetes Care, 32, 416, 10.2337/dc08-1775 · DOI · Paper page
- Jenkins, 2003, Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy, Kidney Int., 64, 817, 10.1046/j.1523-1755.2003.00164.x · DOI · Paper page
- Mattock, 2001, Plasma lipids and urinary albumin excretion rate in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study, Diabet. Med., 18, 59, 10.1046/j.1464-5491.2001.00411.x · DOI
- Rashid, 2003, Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity, Clin. Biochem., 36, 421, 10.1016/S0009-9120(03)00078-X · DOI · Paper page
- Nicoll, 1980, Evaluation of the roles of lipoprotein lipase and hepatic lipase in lipoprotein metabolism: in vivo and in vitro studies in man, Eur. J. Clin. Invest., 10, 487, 10.1111/j.1365-2362.1980.tb02090.x · DOI
- Packard, 1997, Lipoprotein heterogeneity and apolipoprotein B metabolism, Arterioscler. Thromb. Vasc. Biol., 17, 3542, 10.1161/01.ATV.17.12.3542 · DOI · Paper page
- Galeano, 1998, Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity, J. Lipid Res., 39, 1263, 10.1016/S0022-2275(20)32551-7 · DOI · Paper page
- Galeano, 1994, Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size, J. Biol. Chem., 269, 511, 10.1016/S0021-9258(17)42379-9 · DOI · Paper page
- Zheng, 2010, Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype, Circulation, 121, 1722, 10.1161/CIRCULATIONAHA.109.875807 · DOI · Paper page
- Austin, 1988, Low-density lipoprotein subclass patterns and risk of myocardial infarction, JAMA, 260, 1917, 10.1001/jama.1988.03410130125037 · DOI · Paper page
- Bjornheden, 1996, Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system, Atherosclerosis, 123, 43, 10.1016/0021-9150(95)05770-6 · DOI · Paper page
- de Graaf, 1991, Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects, Arterioscler. Thromb., 11, 298, 10.1161/01.ATV.11.2.298 · DOI · Paper page
- Tribble, 2001, Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins, Am. J. Med., 110, 103, 10.1016/S0002-9343(00)00700-2 · DOI · Paper page
- Taskinen, 1987, Alcohol-induced changes in serum lipoproteins and in their metabolism, Am. Heart J., 113, 458, 10.1016/0002-8703(87)90614-4 · DOI · Paper page
- Chait, 1981, Chylomicronemia syndrome in diabetes mellitus, Diabetes Care, 4, 343, 10.2337/diacare.4.3.343 · DOI
- Chait, 1992, Chylomicronemia syndrome, Adv. Intern. Med., 37, 249
- Havel, 1969, Pathogenesis, differentiation and management of hypertriglyceridemia, Adv. Intern. Med., 15, 117
- Kahn, 2003, Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration, Am. J. Clin. Nutr., 78, 928, 10.1093/ajcn/78.5.928 · DOI · Paper page
- Kanaley, 2001, Abdominal fat distribution in pre- and postmenopausal women: the impact of physical activity, age, and menopausal status, Metabolism, 50, 976, 10.1053/meta.2001.24931 · DOI
- Donnelly, 2003, Effects of a 16-month randomized controlled exercise trial on body weight and composition in young, overweight men and women: the Midwest Exercise Trial, Arch. Intern. Med., 163, 1343, 10.1001/archinte.163.11.1343 · DOI · Paper page
- Ross, 1996, Influence of diet and exercise on skeletal muscle and visceral adipose tissue in men, J. Appl. Physiol., 81, 2445, 10.1152/jappl.1996.81.6.2445 · DOI · Paper page
- Duncan, 2005, Prescribing exercise at varied levels of intensity and frequency: a randomized trial, Arch. Intern. Med., 165, 2362, 10.1001/archinte.165.20.2362 · DOI · Paper page
- Thomas, 2000, Preferential loss of visceral fat following aerobic exercise, measured by magnetic resonance imaging, Lipids, 35, 769, 10.1007/s11745-000-0584-0 · DOI
- Williamson, 1992, Weight loss attempts in adults: goals, duration, and rate of weight loss, Am. J. Public Health, 82, 1251, 10.2105/AJPH.82.9.1251 · DOI · Paper page
- Colhoun, 2004, Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial, Lancet, 364, 685, 10.1016/S0140-6736(04)16895-5 · DOI · Paper page
- Dane-Stewart, 2003, Effect of atorvastatin on apolipoprotein B48 metabolism and low-density lipoprotein receptor activity in normolipidemic patients with coronary artery disease, Metabolism, 52, 1279, 10.1016/S0026-0495(03)00281-6 · DOI
- Keech, 2005, Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial, Lancet, 366, 1849, 10.1016/S0140-6736(05)67667-2 · DOI · Paper page
- Kamanna, 2000, Mechanism of action of niacin on lipoprotein metabolism, Curr. Atheroscler. Rep., 2, 36, 10.1007/s11883-000-0093-1 · DOI
- Elam, 2000, Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: a randomized trial. Arterial Disease Multiple Intervention Trial, JAMA, 284, 1263, 10.1001/jama.284.10.1263 · DOI · Paper page
- Goldberg, 2005, A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia, Diabetes Care, 28, 1547, 10.2337/diacare.28.7.1547 · DOI · Paper page
- Hsiao, 2004, Variance-modeled posterior inference of microarray data: detecting gene-expression changes in 3T3-L1 adipocytes, Bioinformatics, 20, 3108, 10.1093/bioinformatics/bth371 · DOI
- Nicholls, 2010, J. Am. Coll. Cardiol., 57, 153, 10.1016/j.jacc.2010.06.055 · DOI
- Dormandy, 2005, Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial, Lancet, 366, 1279, 10.1016/S0140-6736(05)67528-9 · DOI · Paper page
- Lewis, 2011, Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study, Diabetes Care, 34, 916, 10.2337/dc10-1068 · DOI · Paper page
- Nissen, 2011, Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality, Arch. Intern. Med., 170, 1191, 10.1001/archinternmed.2010.207 · DOI · Paper page
Cited by
Dyslipidemia in obesity: Mechanisms and potential targets
Klop, B., Elte, J., & Cabezas, M. (2013) · Nutrients · doi:10.3390/nu5041218 · Cited by 1,665
“to less free cholesterol and anti-oxidative content [60].”
BackgroundTriglyceride Metabolism in the Liver
Alves‐Bezerra, M., & Cohen, D. E. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c170012 · Cited by 1,016
Samson, S. L., & Garber, A. J. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.09.009 · Cited by 746
Issues in Hypertriglyceridemic Pancreatitis: An Update
Scherer, J., Singh, V. P., Pitchumoni, C. S., & Yadav, D. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000436438.60145.5a · Cited by 475
Henderson, D. C., Vincenzi, B., Andrea, N. V., Ulloa, M., & Copeland, P. M. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00115-7 · Cited by 288
Metadata
- Authors
- Subramanian, S., & Chait, A.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Publisher
- Elsevier BV
- Published
- 2012-05
- Volume
- 1821
- Issue
- 5
- Pages
- 819-825
- ISSN
- 1388-1981 (ISSN-L)
- OpenAlex
- W2083230171
- Cited by
- 200
- References
- 33
- FWCI
- 7.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hypertriglyceridemia secondary to obesity and diabetes. https://app.cochat.ai/papers/10.1016/j.bbalip.2011.10.003
- The paper
- Subramanian, S., & Chait, A. (2012). Hypertriglyceridemia secondary to obesity and diabetes. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. https://doi.org/10.1016/j.bbalip.2011.10.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.